Clinical trial
Single Dose Oral Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and 'Adempas' (Riociguat) 2.5 mg Filmtabletten (Film Coated Tablets) in Healthy Adult Male Subjects Under Fasting Conditions
NCT06180096 is registered in ClinicalTrials.gov with Humanis Saglık Anonim Sirketi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Dose Oral Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and 'Adempas' (Riociguat) 2.5 mg Filmtabletten (Film Coated Tablets) in Healthy Adult Male Subjects Under Fasting Conditions
- Lead sponsor
- Humanis Saglık Anonim Sirketi
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 7, 2023
- Completion date
- April 6, 2023
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.